Results 41 to 50 of about 4,879 (225)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension

open access: yesChinese Medical Journal, 2015
Background: The purpose of this article was to clarify the optimal management concerning transjugular intrahepatic portosystemic shunts (TIPSs) and surgical shunting in treating portal hypertension.
Long Huang   +4 more
doaj   +1 more source

Title: S. mansoni trapping in lungs contributes to resistance to reinfection

open access: yesFrontiers in Immunology, 2015
Paul and Pammi's combined research career of 60 plus years focused on preventive vaccine against schistosomiasis. Worm migration studies in rats using 75SE-methionine labeled cercariae and analyzed by autoradiography demonstrated that resistance to ...
Parmjeet Behl Suri, Paul Mark Knopf
doaj   +1 more source

Therapeutic Portacaval Anastomosis: To Shunt or Not to Shunt

open access: yesGastroenterology, 1974
The final report of the Boston Inter-Hospital Liver Group (BILG) study of therapeutic portacaval shunts in this issue of Gastroenterology1 is another giant step for medicine in determining the rightful role of portacaval anastomosis. It is also an appropriate opportunity for an editorial admirer of BILG to praise its work and to try to put it into ...
Harold O. Conn, Harold O. Conn
openaire   +3 more sources

Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes

open access: yesLiver Transplantation, Volume 26, Issue 12, Page 1629-1643, December 2020., 2020
Orthotopic liver transplantation continues to be the only effective therapy for patients with end‐stage liver disease. Unfortunately, many of these patients are not considered transplant candidates, lacking effective therapeutic options that would address both the irreversible progression of their hepatic failure and the control of their portal ...
Paulo Fontes   +4 more
wiley   +1 more source

Techniques for Management of Portal Vein Thrombosis during Liver Transplantation

open access: yesCase Reports in Transplantation, Volume 2020, Issue 1, 2020., 2020
Portal vein thrombosis (PVT) poses a unique challenge in liver transplant. The management of PVT differs according to the extent of thrombosis. Anastomosis of a donor portal vein to a varix is a viable option when an adequate size varix is identified on preoperative imaging or intraoperatively.
Navdeep Singh   +4 more
wiley   +1 more source

PORTACAVAL SHUNT AND LIPID SYNTHESIS [PDF]

open access: yesPediatric Research, 1974
A 12 y.o. girl with homozygous type II hyperlipoproteinemia has had marked improvement following portacaval (PC) shunt (Lancet, ii:944, 1973). In an attempt to explain the reduction in serum cholesterol (chol) levels, 7 dogs were given end-to-side PC anastamoses and 3 had sham operations.
Chase, HP, Starzl, TE
openaire   +2 more sources

Further steps of hepatic stimulatory substance purification [PDF]

open access: yes, 1991
The hepatic stimulatory substance (HSS) extracted from weanling rat livers was purified 381,000-fold using chromatographic techniques including nondissociating polyacrylamide gel electrophoresis (nondenaturing PAGE).
Barone, M   +5 more
core   +1 more source

The incidence of portal vein thrombosis at liver transplantation [PDF]

open access: yes, 1992
The incidence of portal vein thrombosis was examined in 885 patients who received orthotopic liver transplantations for various end‐stage liver diseases between 1989 and 1990. The thrombosis was classified into four grades.
Iwatsuki, S   +3 more
core   +1 more source

Significant Improvement of Survival by Intrasplenic Hepatocyte Transplantation in Totally Hepatectomized Rats

open access: yesCell Transplantation, 1996
The effect of intrasplenic hepatocyte transplantation (HTX) was studied in an experimental model of acute liver failure in rats with chronic liver atrophy.
Birgit A.P.M. Vogels   +3 more
doaj   +1 more source

Effect on the canine Eck fistula liver of intraportal TGF‐β alone or with hepatic growth factors [PDF]

open access: yes, 1992
Transforming growth factor‐β canceled the hepatocyte proliferation caused by transforming growth factor‐α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast,
Alessandro Azzarone   +28 more
core   +1 more source

Home - About - Disclaimer - Privacy